Related Experiment Video
Updated: Mar 22, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
Evaren E Page1, Johanna A Kremer Hovinga2, Deirdra R Terrell3
1Department of Biostatistics and Epidemiology, College of Public Health and Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and.
No abstract available in PubMed .
More Related Videos
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease III: Medical Management
Venous Thrombosis III: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Therapeutic Drug Monitoring: Affecting Factors